BCL2L1 and small cell lung carcinoma: Since AZD8055 was found to selectively suppress MCL-1 expression in SCLC cells, we next evaluated it in combination with DT2216 on the viability of BCL-XL/MCL-1 co-dependent SCLC cells as well as normal cells.